Patent · US Active

Compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them

US10654878B2 · kind B2 · utility

0Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2018
Grant dateMay 19, 2020
Priority date—
Expiry dateOct 4, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65846
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I) wherein: Medicinal products containing the same which are useful in treating conditions requiring a TAFIa inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.